Literature DB >> 9216065

Lens-preferred activity of chicken delta 1- and delta 2-crystallin enhancers in transgenic mice and evidence for retinoic acid-responsive regulation of the delta 1-crystallin gene.

X Li1, A Cvekl, S Bassnett, J Piatigorsky.   

Abstract

There are two tandemly linked delta-crystallin genes [5' delta 1 -delta 2 3'] in the chicken, with the delta 1-crystallin gene being expressed much more highly (50-100-fold) in the embryonic lens than the delta 2-crystallin gene. Previous transfection experiments have shown that a lens-preferred enhancer exists in the third intron of each chicken delta-crystallin gene. In the present investigation we have used transgenic mice to establish that both the chicken delta 1- and delta 2-crystallin enhancers are preferentially active in the mouse lens in combination with their homologous promoter and the chloramphenicol acetyltransferase (CAT) reporter gene. The promoter/ CAT constructs lacking the enhancers were inactive in the transgenic mice. In one case, a truncated delta 2-crystallin promoter (-308/+24) in combination with the enhancer was also active in the Purkinje cells of the cerebellum of the transgenic mice, which could prove useful in future experiments. Finally, retinoic acid receptors (RAR beta) activated the delta 1-crystallin, but not the delta 2-crystallin enhancer in teh recombinant plasmids in cotransfected embryonic chicken lens epithelial cells treated with retinoic acid. This activation did not occur when using the care enhancer (fragment B4) lacking surrounding flanking sequences (fragment B3 and B5) of the enhancer. Together these experiments show that the chicken delta-crystallin enhancers show lens-preference in transgenic mice despite the absence of delta-crystallin in this species and add retinoic acid nuclear receptors to the growing list of transcription factors (including Pax-6, Sox-2, and delta EF3) that directly or indirectly contribute to the high expression of the delta 1-crystallin gene in the lens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9216065     DOI: 10.1002/(SICI)1520-6408(1997)20:3<258::AID-DVG8>3.0.CO;2-6

Source DB:  PubMed          Journal:  Dev Genet        ISSN: 0192-253X


  8 in total

Review 1.  Crystallin genes: specialization by changes in gene regulation may precede gene duplication.

Authors:  Joram Piatigorsky
Journal:  J Struct Funct Genomics       Date:  2003

Review 2.  Genetic and epigenetic mechanisms of gene regulation during lens development.

Authors:  Ales Cvekl; Melinda K Duncan
Journal:  Prog Retin Eye Res       Date:  2007-07-28       Impact factor: 21.198

3.  Related function of mouse SOX3, SOX9, and SRY HMG domains assayed by male sex determination.

Authors:  D E Bergstrom; M Young; K H Albrecht; E M Eicher
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

4.  Aldehyde dehydrogenase class 3 expression: identification of a cornea-preferred gene promoter in transgenic mice.

Authors:  W T Kays; J Piatigorsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  Molecular and cellular aspects of amphibian lens regeneration.

Authors:  Jonathan J Henry; Panagiotis A Tsonis
Journal:  Prog Retin Eye Res       Date:  2010-07-16       Impact factor: 21.198

6.  Gene expression profiles of lens regeneration and development in Xenopus laevis.

Authors:  Erica L Malloch; Kimberly J Perry; Lisa Fukui; Verity R Johnson; Jason Wever; Caroline W Beck; Michael W King; Jonathan J Henry
Journal:  Dev Dyn       Date:  2009-09       Impact factor: 3.780

7.  General utility of the chicken betaB1-crystallin promoter to drive protein expression in lens fiber cells of transgenic mice.

Authors:  Jennifer R Taube; Chun Y Gao; Yoji Ueda; Peggy S Zelenka; Larry L David; Melinda K Duncan
Journal:  Transgenic Res       Date:  2002-08       Impact factor: 2.788

8.  Retinoic acid X receptor in the diploblast, Tripedalia cystophora.

Authors:  Z Kostrouch; M Kostrouchova; W Love; E Jannini; J Piatigorsky; J E Rall
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.